Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nova Pacific Metals Corp. | YQ1 | Sep 27, 2024 | 0.12 | 0.00 |
Novabase - Sociedade Gestora De Participacoes Sociais, S.A. | NVQ | Sep 27, 2024 | 5.70 | +0.89 |
Novabay Pharmaceuticals | B9P | Sep 27, 2024 | 2.80 | 0.00 |
Novacyt | NYZ | Sep 27, 2024 | 0.72 | -1.64 |
Novagold Resources Inc. | NGR | Sep 27, 2024 | 3.86 | -0.05 |
Novanta Inc. - | 1GSN | Sep 27, 2024 | 159.00 | +0.63 |
Novartis AG | NOTA | Sep 27, 2024 | 101.50 | -0.98 |
Novavax, Inc. | NVV1 | Sep 27, 2024 | 11.71 | +8.34 |
Novem Group S.A. | NVM | Sep 27, 2024 | 4.98 | +1.22 |
NOVINA S.A. E ZY 1,16 | T36 | Sep 27, 2024 | 0.24 | -2.26 |
Novo Nordisk A/S | NOVA | Sep 27, 2024 | 108.00 | -2.70 |
Novo Resources Corp | 1NOR | 0.00 | 0.00 | |
Novo Resources Corp | 1NO | Sep 27, 2024 | 0.05 | 0.00 |
NovoCure Limited - Ordinary Shares | 038 | Sep 27, 2024 | 13.98 | -2.17 |
NOVONIX ADR | GC30 | Sep 27, 2024 | 1.64 | +16.31 |
Novonix Limited | GC3 | Sep 27, 2024 | 0.44 | +20.93 |
NOVOTEK AB B SK-,25 | Z9D | Sep 27, 2024 | 5.14 | 0.00 |
Novozymes AS | NZM | Sep 27, 2024 | 63.00 | -0.79 |
Novozymes B | NZM2 | Sep 27, 2024 | 63.30 | -0.44 |
Novra Technologies Inc. | 7CV | Sep 27, 2024 | 0.05 | 0.00 |
Novus Holdings Limited | N09 | Sep 27, 2024 | 0.32 | 0.00 |
NOW Inc. | 11N | Sep 27, 2024 | 11.10 | -1.77 |
NP3 Fastigheter | N33 | Sep 27, 2024 | 23.05 | +1.10 |
NPC Inc | 59N | Sep 27, 2024 | 6.25 | +2.46 |
NRC Group | 8NR | Sep 27, 2024 | 0.26 | -9.93 |
NRG Energy Inc. | NRA | Sep 27, 2024 | 80.48 | +0.02 |
NRJ Group | NR8 | Sep 27, 2024 | 7.56 | +0.27 |
NRW Holdings Limited | 3NR | Sep 27, 2024 | 2.16 | -0.92 |
Ns United Kaiun Kaisha, Ltd. | 8WN | Sep 27, 2024 | 28.00 | -2.78 |
NSE SA | 7YM | Sep 27, 2024 | 28.10 | -4.75 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.